IDEXX Laboratories, Inc. (IDXX) Stock Price Today
Aura AI Summary
Key Stats
- $42.18BMarket Cap
- -Volume
- HealthSector
- $766.6852W High
- $526.4452W Low
- -Typical Hold Time
- $43.08BEnterprise Value
- -Div Yield
- -Trading Activity
Track IDEXX Laboratories, Inc. (IDXX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $526.44 and a high of $766.68, highlighting its annual price range. Buy and sell IDEXX Laboratories, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Most Recent News
Concerns over AI sector's circular financing are overstated; diversification into Small Cap and Value stocks advised.
Concerns about circular financing in the AI sector are exaggerated, as such practices are common and serve as risk mitigation in mature industries. The AI industry's higher scrutiny is due to its immaturity and concentrated risks, not the novelty of ...
TSMC and Samsung commit to ASML's $400M High NA EUV machines for advanced chip production by 2030.
TSMC and Samsung, two leading chipmakers, have committed to using ASML's High NA EUV lithography machines, which cost around $400 million each, to produce more advanced chips. Samsung plans to adopt this technology for DRAM memory manufacturing start...
Closed-end fund market mixed; activist push at BPRE targets management amid weak performance.
The closed-end fund (CEF) market showed mixed results last week, with fixed-income sectors generally outperforming and sector discounts returning to long-term averages. Activist investor Saba is pushing for management changes at BPRE due to weak perf...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.